We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Mattel
MAT
$3.76B
| $1.01M | ﹤0.01% |
51,461
-8,904
| -15% | -$161K |
|
1127
Wyndham Hotels & Resorts
WH
$5.06B
| $1M | ﹤0.01% |
14,652
-667
| -4% | -$45.5K |
|
1128
Acadia Healthcare
ACHC
$2.62B
| $1M | ﹤0.01% |
12,582
-167
| -1% | -$12.1K |
|
1129
Urban Outfitters
URBN
$6.6B
| $1M | ﹤0.01% |
30,202
-16,117
| -35% | -$470K |
|
1130
Lithia Motors
LAD
$7.46B
| $1,000K | ﹤0.01% |
3,288
+27
| +0.8% | +$6.47K |
|
1131
Universal Logistics Holdings
ULH
$497M
| $1,000K | ﹤0.01% |
34,702
-6,936
| -17% | -$192K |
|
1132
Axalta
AXTA
$7.12B
| $999K | ﹤0.01% |
30,438
-2,569
| -8% | -$79.7K |
|
1133
Cullen/Frost Bankers
CFR
$9.91B
| $996K | ﹤0.01% |
9,261
-337
| -4% | -$35.2K |
|
1134
CBIZ
CBZ
$2.96B
| $986K | ﹤0.01% |
18,498
-1,702
| -8% | -$87.6K |
|
1135
Constellium
CSTM
$3.51B
| $984K | ﹤0.01% |
57,192
+16,728
| +41% | +$257K |
|
1136
OGE Energy
OGE
$9.5B
| $982K | ﹤0.01% |
27,356
-4,934
| -15% | -$182K |
|
1137
Western New England Bancorp
WNEB
$276M
| $980K | ﹤0.01% |
167,836
-428
| -0.3% | -$2.78K |
|
1138
Omega Healthcare
OHI
$14.2B
| $980K | ﹤0.01% |
31,917
+3,379
| +12% | +$97.6K |
|
|
LPRO
1139
DELISTED
Open Lending Corp
LPRO
| $977K | ﹤0.01% |
93,006
-889,942
| -91% | -$7.87M |
|
1140
Vertiv
VRT
$92.2B
| $974K | ﹤0.01% |
39,334
+2,411
| +7% | +$41.4K |
|
1141
Blue Bird Corp
BLBD
$1.95B
| $974K | ﹤0.01% |
+43,308
| New | +$927K |
|
1142
Chesapeake Utilities
CPK
$3.13B
| $963K | ﹤0.01% |
8,095
+242
| +3% | +$30.6K |
|
|
AIRC
1143
DELISTED
Apartment Income REIT Corp.
AIRC
| $962K | ﹤0.01% |
26,659
-947
| -3% | -$33.7K |
|
|
SKX
1144
DELISTED
Skechers
SKX
| $962K | ﹤0.01% |
18,266
-970
| -5% | -$49.7K |
|
1145
Autoliv
ALV
$8.49B
| $950K | ﹤0.01% |
11,168
-401
| -3% | -$34.7K |
|
1146
New York Times
NYT
$11.7B
| $940K | ﹤0.01% |
23,871
-785
| -3% | -$29.9K |
|
1147
Immunovant
IMVT
$7.51B
| $938K | ﹤0.01% |
49,425
-3,067
| -6% | -$57.2K |
|
|
SGI
1148
Somnigroup International
SGI
$13.5B
| $936K | ﹤0.01% |
23,361
+2,651
| +13% | +$99.7K |
|
1149
Old Republic International
ORI
$9.87B
| $931K | ﹤0.01% |
36,987
-4,199
| -10% | -$105K |
|
1150
Dyne Therapeutics
DYN
$3.23B
| $927K | ﹤0.01% |
82,400
-180,796
| -69% | -$2.13M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.